cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Seer Inc
2 own
2 watching
Current Price
$2.29
$-0.03
(-1.29%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
103.2M
52-Week High
52-Week High
2.625
52-Week Low
52-Week Low
1.51000
Average Volume
Average Volume
0.27M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization103.2M
icon52-Week High2.625
icon52-Week Low1.51000
iconAverage Volume0.27M
iconDividend Yield--
iconP/E Ratio--
What does the Seer Inc do?
We aim to enable exceptional scientific outcomes by commercializing transformative products for researchers to unlock deep, unbiased biological information. Our initial product, the Proteograph Product Suite (Proteograph), will leverage our proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Our Proteograph Product Suite is an integrated solution that is comprised of consumables, an automation instrument and software. --- We were incorporated in Delaware on March 16, 2017, under the name Seer Biosciences, Inc., and changed our name to Seer, Inc. on July 16, 2018. Our principal executive offices are located at 3800 Bridge Parkway, Suite 102, Redwood City, California 94065. Our telephone number is 650-543-0000. Our website address is www.seer.bio.
Read More
How much money does Seer Inc make?
News & Events about Seer Inc.
Globe Newswire
1 year ago
Peptide-level insights from deep, unbiased proteomics enable protein variant analysis of patient samples, revealing potential non-small cell lung cancer biomarkersREDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive ...
Benzinga
1 year ago
read more...
Zolmax
1 year ago
Seer (NASDAQ:SEER Get Rating) had its price target trimmed by Morgan Stanley from $11.00 to $10.00 in a research report sent to investors on Tuesday , Benzinga reports. The brokerage currently has an equal weight rating on the stock. Separately, Bank of America downgraded shares of Seer from a ...
CNW Group - News Releases
2years ago
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS Canada NewsWire HUNTSVILLE, Ala., Dec. 14, 2022 Creates a single source...
Globe Newswire
2years ago
Annual award from The Scientist celebrates transformative products like Seers Proteograph Product Suite, which make unbiased, at-scale proteomics accessibleREDWOOD CITY, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new ...
Frequently Asked Questions
Frequently Asked Questions
What is Seer Inc share price today?
plus_minus_icon
Can Indians buy Seer Inc shares?
plus_minus_icon
How can I buy Seer Inc shares from India?
plus_minus_icon
Can Fractional shares of Seer Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Seer Inc stocks?
plus_minus_icon
What is today’s traded volume of Seer Inc?
plus_minus_icon
What is today’s market capitalisation of Seer Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Seer Inc?
plus_minus_icon
What percentage is Seer Inc down from its 52-Week High?
plus_minus_icon
What percentage is Seer Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.29
$-0.03
(-1.29%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$2.65
$0.09 (3.32 %)
PMV PHARMACEUTICALS INC
PMV PHARMACEUTICALS INC
$1.35
$-0.04 (-2.88 %)
Clene Inc
Clene Inc
$4.84
$-0.11 (-2.22 %)
Athira Pharma Inc
Athira Pharma Inc
$0.53
$-0.01 (-0.96 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$2.65
$0.09 (3.32 %)
PMV PHARMACEUTICALS INC
PMV PHARMACEUTICALS INC
$1.35
$-0.04 (-2.88 %)
Clene Inc
Clene Inc
$4.84
$-0.11 (-2.22 %)
Athira Pharma Inc
Athira Pharma Inc
$0.53
$-0.01 (-0.96 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00